Exploratory analysis of the economically justifiable price of tezepelumab for asthma severe in Colombia.

Autor: Buendía JA; Departamento de Farmacología y Toxicología, Grupo de Investigación en Farmacología y Toxicología, Universidad de Antioquia, Medellín, Colombia.; Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia., Zuluaga AF; Department of Pharmacology and Toxicology, University of Antioquia, Medellín, Colombia.

Publikováno v: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Dec 13, pp. 1-10. Date of Electronic Publication: 2024 Dec 13.

Validation of a new strategy for the identification of SARS-CoV-2 variants by sequencing the spike gene by Sanger.

Autor: Murillo E; Laboratorio Integrado de Medicina Especializada (LIME), Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Antioquia, Colombia., Palacio-Rua K; Laboratorio Integrado de Medicina Especializada (LIME), Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Antioquia, Colombia., Afanador-Ayala C; Laboratorio Integrado de Medicina Especializada (LIME), Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Antioquia, Colombia., García-Correa JF; Laboratorio Integrado de Medicina Especializada (LIME), Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Antioquia, Colombia., Zuluaga AF; Laboratorio Integrado de Medicina Especializada (LIME), Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Antioquia, Colombia. Electronic address: andres.zuluaga@udea.edu.co.

Publikováno v: Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2023 May; Vol. 41 (5), pp. 284-289. Date of Electronic Publication: 2022 Oct 17.

A proof of concept reinforcement learning based tool for non parametric population pharmacokinetics workflow optimization.

Autor: Otalvaro JD; Laboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Bioinstrumentation and Clinical Engineering Research Group, Engineering Department, University of Antioquia, Medellín, Colombia.; Laboratory of Integrated and Specialized Medicine, Medical School, University of Antioquia, Medellín, Colombia., Yamada WM; Laboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA., Hernandez AM; Bioinstrumentation and Clinical Engineering Research Group, Engineering Department, University of Antioquia, Medellín, Colombia., Zuluaga AF; Laboratory of Integrated and Specialized Medicine, Medical School, University of Antioquia, Medellín, Colombia., Chen R; Laboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA., Neely MN; Laboratory of Applied Pharmacokinetics and Bioinformatics, Department of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA. mneely@chla.usc.edu.

Publikováno v: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2023 Feb; Vol. 50 (1), pp. 33-43. Date of Electronic Publication: 2022 Dec 07.

Population Pharmacokinetic Models of Antituberculosis Drugs in Patients: A Systematic Critical Review.

Autor: Otalvaro JD; CIEMTO: Drug and Poison Information and Research Center, Laboratorio Integrado de Medicina Especializada (LIME), IPS Universitaria, Facultad de Medicina, Universidad de Antioquia; and.; Bioinstrumentation and Clinical Engineering Research Group-GIBIC, Bioengineering Department, Engineering Faculty, Universidad de Antioquia, Medellin, Colombia., Hernandez AM; Bioinstrumentation and Clinical Engineering Research Group-GIBIC, Bioengineering Department, Engineering Faculty, Universidad de Antioquia, Medellin, Colombia., Rodriguez CA; CIEMTO: Drug and Poison Information and Research Center, Laboratorio Integrado de Medicina Especializada (LIME), IPS Universitaria, Facultad de Medicina, Universidad de Antioquia; and., Zuluaga AF; CIEMTO: Drug and Poison Information and Research Center, Laboratorio Integrado de Medicina Especializada (LIME), IPS Universitaria, Facultad de Medicina, Universidad de Antioquia; and.

Publikováno v: Therapeutic drug monitoring [Ther Drug Monit] 2021 Feb 01; Vol. 43 (1), pp. 108-115.

A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone.

Autor: Jimenez-Toro I; GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia.; Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia., Rodriguez CA; GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia.; Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia., Zuluaga AF; GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia.; Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia., Otalvaro JD; Integrated Laboratory of Specialized Medicine (LIME), School of Medicine, University of Antioquia, Medellín, Colombia., Vesga O; GRIPE, School of Medicine, University of Antioquia, Medellín, Colombia.; Infectious Diseases Unit, Hospital Universitario San Vicente Fundación, Medellín, Colombia.

Publikováno v: PloS one [PLoS One] 2020 Dec 08; Vol. 15 (12), pp. e0243365. Date of Electronic Publication: 2020 Dec 08 (Print Publication: 2020).